Search Results - "Leung, Joseph C.K."

Refine Results
  1. 1

    Kidney injury molecule-1: More than just an injury marker of tubular epithelial cells? by Lim, Ai Ing, Tang, Sydney C.W., Lai, Kar Neng, Leung, Joseph C.K.

    Published in Journal of cellular physiology (01-05-2013)
    “…Regardless of the original causes and etiology, the progression to renal function declines follows a final common pathway associated with tubulointerstitial…”
    Get full text
    Journal Article
  2. 2

    The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis by Lok, Sarah W Y, Yiu, Wai Han, Li, Hongyu, Xue, Rui, Zou, Yixin, Li, Bin, Chan, Kam Wa, Chan, Loretta Y Y, Leung, Joseph C K, Lai, Kar Neng, Tang, Sydney C W

    Published in Clinical science (1979) (13-11-2020)
    “…Protease-activated receptor (PAR)-1 has emerged as a key profibrotic player in various organs including kidney. PAR-1 activation leads to deposition of…”
    Get more information
    Journal Article
  3. 3

    Distinct role of matrix metalloproteinase-3 in kidney injury molecule-1 shedding by kidney proximal tubular epithelial cells by Lim, Ai Ing, Chan, Loretta Y.Y., Lai, Kar Neng, Tang, Sydney C.W., Chow, Chui Wa, Lam, Man Fai, Leung, Joseph C.K.

    “…Tubulointerstitial injury is a common pathway in progressive renal impairment and human proximal tubular epithelial cells (PTEC) play a crucial role in this…”
    Get full text
    Journal Article
  4. 4

    Recent advances in the understanding and management of IgA nephropathy by Lai, Kar Neng, Leung, Joseph C K, Tang, Sydney C W

    Published in F1000 research (2016)
    “…Since its first description in 1968, IgA nephropathy has remained the most common form of primary glomerulonephritis leading to chronic kidney disease in…”
    Get full text
    Journal Article
  5. 5

    Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy by MIAO LIN, WAI HAN YIU, HAO JIA WU, CHAN, Loretta Y. Y, LEUNG, Joseph C. K, WO SHING AU, KWOK WAH CHAN, KAR NENG LAI, TANG, Sydney C. W

    “…Inflammation contributes to the tubulointerstitial lesions of diabetic nephropathy. Toll-like receptors (TLRs) modulate immune responses and inflammatory…”
    Get full text
    Journal Article
  6. 6

    MEDIATORS OF INFLAMMATION AND FIBROSIS by Lai, Kar Neng, Tang, Sydney C.W, Leung, Joseph C.K

    Published in Peritoneal dialysis international (01-06-2007)
    “…Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, PR China Correspondence to: K.N. Lai,…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress by Yiu, Wai Han, Wong, Dickson W L, Wu, Hao Jia, Li, Rui Xi, Yam, Irene, Chan, Loretta Y Y, Leung, Joseph C K, Lan, Hui Yao, Lai, Kar Neng, Tang, Sydney C W

    Published in Kidney international (01-02-2016)
    “…Kallistatin is a serine protease inhibitor with anti-inflammatory, anti-angiogenic, and anti-oxidative properties. Since oxidative stress plays a critical role…”
    Get more information
    Journal Article
  8. 8

    Role of Mesangial-Podocytic-Tubular Cross-Talk in IgA Nephropathy by Leung, Joseph C.K., Lai, Kar Neng, Tang, Sydney C.W.

    Published in Seminars in nephrology (01-09-2018)
    “…IgA nephropathy (IgAN), a common primary glomerulonephritis worldwide, is associated with a substantial risk of progression to end-stage renal failure. The…”
    Get full text
    Journal Article
  9. 9

    The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy by Lin, Miao, Yiu, Wai Han, Li, Rui Xi, Wu, Hao Jia, Wong, Dickson W L, Chan, Loretta Y Y, Leung, Joseph C K, Lai, Kar Neng, Tang, Sydney C W

    Published in Kidney international (01-05-2013)
    “…We recently showed that Toll-like receptor (TLR) TLR4 was overexpressed in the human diabetic kidney, which could promote tubular inflammation. Here we…”
    Get more information
    Journal Article
  10. 10

    Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling by Yiu, Wai Han, Li, Ye, Lok, Sarah W Y, Chan, Kam Wa, Chan, Loretta Y Y, Leung, Joseph C K, Lai, Kar Neng, Tsu, James H L, Chao, Julie, Huang, Xiao-Ru, Lan, Hui Yao, Tang, Sydney C W

    Published in Clinical science (1979) (12-02-2021)
    “…Kallistatin is a multiple functional serine protease inhibitor that protects against vascular injury, organ damage and tumor progression. Kallistatin treatment…”
    Get more information
    Journal Article
  11. 11

    Long-term study of mycophenolate mofetil treatment in IgA nephropathy by Tang, Sydney C.W., Tang, Anthony W.C., Wong, Sunny S.H., Leung, Joseph C.K., Ho, Yiu Wing, Lai, Kar Neng

    Published in Kidney international (01-03-2010)
    “…Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is controversial, we extended our original study by following 40…”
    Get full text
    Journal Article
  12. 12

    Inflammation in peritoneal dialysis by Lai, Kar Neng, Leung, Joseph C K

    Published in Nephron. Clinical practice (01-01-2010)
    “…During peritoneal dialysis, peritoneal cells are repeatedly exposed to a non-physiological hypertonic environment with high glucose content and low pH. Current…”
    Get more information
    Journal Article
  13. 13

    Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy by Tang, Sydney, Leung, Joseph C.K., Chan, Loretta Y.Y., Lui, Yun Hoi, Tang, Colin S.O., Kan, Chi Hang, Ho, Yiu Wing, Lai, Kar Neng

    Published in Kidney international (01-08-2005)
    “…Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Mycophenolate mofetil (MMF) is increasingly used to treat primary glomerulopathies…”
    Get full text
    Journal Article
  14. 14

    Tubule-specific deletion of LincRNA-p21ameliorates lipotoxic kidney injury by Li, Bin, Leung, Joseph C K, Chan, Loretta Y Y, Li, Hong-Yu, Yiu, Wai-Han, Lok, Sarah W Y, Xue, Rui, Zou, Yi-Xin, Chen, Wei, Lai, Kar-Neng, Tang, Sydney C W

    Published in Molecular therapy. Nucleic acids (03-12-2021)
    “…Lipotoxicity has been implicated in the pathogenesis of obesity-related kidney damage and propagates chronic kidney injury like diabetic kidney disease;…”
    Get full text
    Journal Article
  15. 15

    Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure by Chan, Loretta Y Y, Leung, Joseph C K, Lai, Kar Neng

    Published in Clinical and experimental nephrology (01-12-2004)
    “…IgA nephropathy (IgAN) runs a highly variable clinical course with frequent involvement of tubulointerstitial damage. Notably, renal progression correlates…”
    Get full text
    Journal Article
  16. 16

    Lamivudine in hepatitis B-associated membranous nephropathy by Tang, Sydney, Lai, Fernand Mac-Moune, Lui, Yun Hoi, Tang, Colin S.O., Kung, Nelson N.S., Wing Ho, Yiu, Chan, Kwok Wah, Leung, Joseph C.K., Neng Lai, Kar

    Published in Kidney international (01-10-2005)
    “…Lamivudine in hepatitis B-associated membranous nephropathy. Although lamivudine is effective for treatment of chronic hepatitis B (HBV) infection, its…”
    Get full text
    Journal Article
  17. 17

    A Study of the Clinical and Biochemical Profile of Peritoneal Dialysis Fluid Low in Glucose Degradation Products by Lai, Kar Neng, Lam, Man Fai, Leung, Joseph C K, Chan, Loretta Y, Lam, Christopher W K, Chan, Iris H S, Chan, Hoi Wong, Li, Chun Sang, Wong, Sunny S H, Ho, Yiu Wing, Cheuk, Au, Tong, Matthew K L, Tang, Sydney C W

    Published in Peritoneal dialysis international (01-05-2012)
    “…Although peritoneal dialysis (PD) is a widely accepted form of renal replacement therapy, concerns remain regarding the bioincompatible nature of standard PD…”
    Get full text
    Journal Article
  18. 18

    Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy by Lai, Kar Neng, Chan, Loretta Y. Y., Guo, Hong, Tang, Sydney C. W., Leung, Joseph C. K.

    Published in Pediatric nephrology (Berlin, West) (01-02-2011)
    “…Our recent in vitro study demonstrated peroxisome proliferator-activated receptor-γ (PPAR−γ) agonist potentiated the anti-inflammatory effect of angiotensin…”
    Get full text
    Journal Article
  19. 19

    Peritoneal Adipocytes and Their Role in Inflammation during Peritoneal Dialysis by Lai, Kar Neng, Leung, Joseph C. K.

    Published in Mediators of Inflammation (01-01-2010)
    “…Adipose tissue is a major site of chronic inflammation associated with peritoneal dialysis (PD) frequently complicating peritonitis. Adiposity-associated…”
    Get full text
    Journal Article
  20. 20

    Crosstalk between peroxisome proliferator-activated receptor-γ and angiotensin II in renal tubular epithelial cells in IgA nephropathy by Xiao, Jing, Leung, Joseph C.K, Chan, Loretta Y.Y, Tang, Sydney C.W, Lai, Kar Neng

    Published in Clinical immunology (Orlando, Fla.) (01-08-2009)
    “…Abstract Our recent study suggested that peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist attenuates inflammatory response in activated tubular…”
    Get full text
    Journal Article